Search fresh public links, source activity, and post angles for Weight-Loss Medication.
Fresh curated links around weight-loss medication are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
An authoritative look at current FDA-approved weight loss medications, their brands and results, and how obesity intersects with disability
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to...
Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker...
There is a misunderstanding that has taken hold in how people speak about the popular “weight loss” medications like Ozempic and Wegovy. They are often described as drugs that caus...
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
From GLP-1s to weight-loss pills, there are plenty of medications promising to help us reach our health goals. Enter phentermine, a prescription weight-loss pill for short-term use...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
The FDA has approved a pill from Eli Lilly that could change how millions of Americans take medications to lose weight. The drug is the second GLP-1 pill approved by federal regula...
FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for M...
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-relate...
Learn about retatrutide, a new weight-loss drug that works differently than other GLP-1s and helped patients in a clinical trial lose up to 85 pounds.
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
The FDA's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.
Bariatric surgery and GLP-1 medications like Wegovy and Zepbound are the two most effective ways to shed pounds.A recent JAMA study shows both methods dramatically cut body fat wit...
The tablet is not yet available in the UK but was approved in the US in December
THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most d...
The meds arrived with considerable fanfare. Semaglutide, tirzepatide, the whole GLP-1 family: drugs that could, apparently, do something medicine had never managed well before. Shr...
Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a powerful metabolic enhancer directly into target cells....
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.